Patients with Genotypic NRTI Resistance Treated with Bictegravir/Emtricitabine/Tenofovir Alafenamide
There is no known resistance to the individual components of the HIV medication bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). The effectiveness of B/F/TAF has been demonstrated ...